Piper Sandler Maintains Overweight on CME Group, Lowers Price Target to $295

CME Group Inc. Class A

CME Group Inc. Class A

CME

0.00

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ: CME) with a Overweight and lowers the price target from $329 to $295.